EMAIL DETAILS
SUBJECT:
Re: Thank You
PRI: NORMAL
FROM:
E
eschwerin@rosemontseneca.com
DATE:
2012-03-05 18:47:05
MSG_ID:
<3032C862-A38D-4B14-9433-51BC4B2E6F64@rosemontseneca.com>
RECIPIENTS:
TO:
M
michael solimene
<msolimene@avjetbiotech.com>
CC:
H
Hunter Biden
<hbiden@rosemontseneca.com>
L
Laird Bunch
<lbunch@bfpsir.com>
M
Marty Oliver
<moliver@avjetbiotech.com>
N
ncallahan@rosemontseneca.com
R
rwalker@rosemontseneca.com
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Thanks, Michael. It was good to meet you as well and thanks for taking the time to bring the team by our offices. Sounds like you are poised to do some great things. Look forward to continuing the discussions as well. Best, Eric Eric D. Schwerin Rosemont Seneca Partners, LLC 1010 Wisconsin Ave., NW Suite 705 Washington, DC 20007 (202) 333-1880 eschwerin@rosemontseneca.com P Consider the environment before printing this email. On Mar 5, 2012, at 1:44 PM, michael solimene wrote: Eric and Rob, Thanks for taking the time on Wednesday to meet our lead scientists and hear our company story. Later this week I'll be sending out our series "B" financing pitch book which will provide the company's detailed growth plans for the next 18-24 months (and I also hope to complete our long awaited rebranding this week!). Neil Callahan and I are scheduled to speak on Friday but if I can provide any additional information regarding our company, please don't hesitate to ask. Thanks again for accommodating us and I look forward to our continued discussions. Best regards, Michael Michael Solimene Chief Executive Officer Avjet Biotech, Inc 203-257-4337
METADATA:
THREAD:
INDEX:
AdhhoLdgGUAbm393QcqR4HUyAE+lGg==
REFERENCES:
REPLY_TO:
<CA+mX6QP+LPN71jWCtZTAz4dE-WTVeQncw67Xv8UcnzoSGy+_uQ@mail.gmail.com>
REFS:
<CA+mX6QP+LPN71jWCtZTAz4dE-WTVeQncw67Xv8UcnzoSGy+_uQ@mail.gmail.com>